Other Capital Market Information | 11 June 2018 10:13
Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para.
1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of
Delegated Regulation (EU) 2016/1052
11.06.2018 / 10:13
Dissemination of a Post-admission Duties announcement transmitted by DGAP -
a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
- Share buy-back - 2nd Interim Report and Final Report
In the period from 4 June 2018 until and including 8 June 2018, a total of
213,226 shares were repurchased within the framework of the share buy-back
programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical
Care'), which was announced on 25 May 2018 pursuant to Art. 5 para. 1 lit.
a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated
Regulation (EU) 2016/1052.
Day of repurchase Aggregated volume in Weighted average share
number of shares price in EUR
4 June 2018 43,500 85.3555
5 June 2018 43,500 86.6331
6 June 2018 42,294 86.7213
7 June 2018 42,863 86.7374
8 June 2018 41,069 86.3573
The total volume of shares repurchased within the framework of this share
buy-back in the period from 28 May 2018 until and including 8 June 2018
therefore amounts to 431,000 shares. The weighted average share price paid
for these shares amounted to EUR 86.3828. This concludes the share buy-back
programme.
The purchase of shares of Fresenius Medical Care within the framework of
the share buy-back programme was carried out exclusively on the Frankfurt
Stock Exchange via the XETRA trading platform by a credit institution
commissioned by Fresenius Medical Care.
Detailed information on the transactions pursuant to Art. 2 para. 3 of
Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical
Care's website at www.freseniusmedicalcare.com under section Investors.
Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board
Bad Homburg v.d.H., 11 June 2018
---------------------------------------------------------------------------
11.06.2018 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Internet: www.freseniusmedicalcare.com
End of News DGAP News Service